Boehringer Ingelheim Press Releases

Boehringer Ingelheim and Orexo report progress in their pain and inflammatory diseases collaboration

Boehringer Ingelheim and Orexo report progress in their pain and inflammatory diseases collaboration

New subgroup analysis of the LUX-Lung 1 trial suggests benefit from afatinib* in lung cancer patients likely to have EGFR mutations

Trial indicates that BIBF1120 may preserve lung function in patients with idiopathic Pulmonary Fibrosis (IPF)

Boehringer Ingelheim steps up to the challenge in support of World Diabetes Day

Collaboration of Boehringer Ingelheim and VTU Technology in Technology and Marketing benefits customers with broader services

Boehringer Ingelheim RCV and Fresenius Kabi successfully coupled HES to a therapeutic protein in an industrial scale applying Fresenius Kabi’s HESylation® Technology 

Dabigatran etexilate demonstrates substantial clinical benefits in atrial fibrillation patients with prior stroke or transient ischaemic attack

Boehringer Ingelheim's oral hepatitis C protease inhibitor and polymerase inhibitor combination shows rapid viral response without use of pegylated interferon

Heinrich Wieland Prize goes to scientist for work on key structures in human fatty acid synthesis

PRADAX™ (dabigatran etexilate) gains approval in Canada for stroke prevention in atrial fibrillation

Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DART™-Based Antibody Therapeutics

US FDA Approves Pradaxa® (dabigatran etexilate) – a breakthrough treatment for stroke risk reduction in non-valvular atrial fibrillation

European Medicines Agency approves TWYNSTA® (telmisartan plus amlodipine) a new single pill combination that delivers powerful and consistent blood pressure reductions throughout 24 hours

Afatinib (BIBW 2992*) triples progression free survival in phase III study in lung cancer patients

Following regulatory feedback Boehringer Ingelheim decides to discontinue flibanserin development

Boehringer Ingelheim lays the foundations in Hanover for its European Veterinary Research Center

Boehringer Ingelheim microParts inaugurates new inhaler factory